ROCHESTER, N.Y., Nov. 2, 2023
/PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix"
or, the "Company"), a leading supplier of smart glasses and
Augmented Reality (AR) technology and products, today announced a
partnership with EDAP TMS SA ("EDAP"), a global leader in robotic
energy-based therapies, whereby Vuzix will supply its M400 smart
glasses to be used in conjunction with EDAP's Focal One
Robotic High Intensity Focused Ultrasound (HIFU) Platform for
device setup, troubleshooting, and applications use. Use of Vuzix
smart glasses helps ensure that hospitals using the system will be
able to make full use of it and provide the highest level of
patient care. EDAP plans to ship a pair of M400 smart glasses with
every HIFU unit they ship.
The Focal One system uses high-performance, high-intensity,
focused ultrasound to achieve precision targeting and destruction
of a portion of the patient's prostate while sparing healthy
surrounding tissue, thereby reducing side effects. Due to the
complexity of the equipment, surgeon-operators need a hands-on demo
so they can interact with the system, and ask questions to a
skilled operator, usually a surgeon who is trained and has already
used the device in the operating room. Without this level of
interaction, it is extremely challenging to accurately convey the
uses and operation of the system. Additionally, many hospitals that
have already purchased the system are as of yet unable to get the
full benefit of the system due to lack of training in actual use.
Uses Vuzix smart glasses facilitates the hands-free level of
remote support necessary to address these issues.
To learn more about the Focal One platform and its use of the
Vuzix smart glasses, you can download the case study
at https://vuzix-website.s3.amazonaws.com/files/Content/case-studies/Vuzix-UseCase-FocalOne-v4.pdf
About EDAP TMS SA
A recognized leader in the global therapeutic ultrasound market.
EDAP TMS develops, manufactures, promotes and distributes worldwide
minimally invasive medical devices for various pathologies using
ultrasound technology. By combining the latest technologies in
imaging and treatment modalities in its complete range of Robotic
HIFU devices, EDAP TMS introduced the Focal One® in Europe and in the U.S. as an answer to all
requirements for ideal prostate tissue ablation. With the addition
of the ExactVu™ Micro-Ultrasound device, EDAP TMS is now the only
company offering a complete solution from diagnostics to focal
treatment of Prostate Cancer. EDAP TMS also produces and
distributes other medical equipment including the Sonolith® i-move
lithotripter and lasers for the treatment of urinary tract stones
using extra-corporeal shockwave lithotripsy (ESWL). For more
information on the Company, please visit http://www.edap-tms.com,
www.us.hifu-prostate.com and www.focalone.com.
About Vuzix Corporation
Vuzix is a leading designer, manufacturer and marketer of Smart
Glasses and Augmented Reality (AR) technologies and products for
the enterprise, medical, defense and consumer markets. The
Company's products include head-mounted smart personal display and
wearable computing devices that offer users a portable high-quality
viewing experience, provide solutions for mobility, wearable
displays and augmented reality, as well OEM waveguide optical
components and display engines. Vuzix holds more than 325 patents
and patents pending and numerous IP licenses in the fields of
optics, head-mounted displays, and augmented reality Video Eyewear
field. Moviynt, an SAP Certified ERP SaaS logistics solution
provider, is a Vuzix wholly owned subsidiary. The Company has won
Consumer Electronics Show (or CES) awards for innovation for the
years 2005 to 2023 and several wireless technology innovation
awards among others. Founded in 1997, Vuzix is a public company
(NASDAQ: VUZI) with offices in: Rochester, NY; Oxford, UK; Munich,
Germany; and Kyoto and
Tokyo, Japan. For more
information, visit the Vuzix website, Twitter and Facebook
pages.
Forward-Looking Statements Disclaimer
Certain statements contained in this news release are
"forward-looking statements" within the meaning of the Securities
Litigation Reform Act of 1995 and applicable Canadian securities
laws. Forward-looking statements contained in this release relate
to Vuzix Smart Glasses, our relationship with EDAP TMS SA and its
customers, future business opportunities, the planned practice of
bundling an M400 with each HiFi unit shipped, and among other
things the Company's leadership in the Smart Glasses and AR display
industry. They are generally identified by words such as
"believes," "may," "expects," "anticipates," "should" and similar
expressions. Readers should not place undue reliance on such
forward-looking statements, which are based upon the Company's
beliefs and assumptions as of the date of this release. The
Company's actual results could differ materially due to risk
factors and other items described in more detail in the "Risk
Factors" section of the Company's Annual Reports and MD&A filed
with the United States Securities and Exchange Commission and
applicable Canadian securities regulators (copies of which may be
obtained at www.sedar.com or www.sec.gov). Subsequent events and
developments may cause these forward-looking statements to change.
The Company specifically disclaims any obligation or intention to
update or revise these forward-looking statements as a result of
changed events or circumstances that occur after the date of this
release, except as required by applicable law.
Media and Investor Relations Contact:
Ed McGregor, Director of Investor
Relations,
Vuzix
Corporation
ed_mcgregor@vuzix.com
Tel: (585) 359-5985
Vuzix Corporation, 25 Hendrix Road, West Henrietta, NY 14586 USA,
Investor Information – IR@vuzix.com
www.vuzix.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/vuzix-announces-partnership-with-edap-tms-to-supply-smart-glasses-for-its-focal-one-robotic-high-intensity-focused-ultrasound-platform-301976435.html
SOURCE Vuzix Corporation
